UPSC Editorial Analysis: US Tariff Shock on Pharmaceuticals and Implications for India
Kartavya Desk Staff
*General Studies-2; Topic: Effect of policies and politics of developed and developing countries on India’s interests, Indian diaspora.*
Introduction
• In September 2025, US President Donald Trump announced a fresh round of tariffs: 100% tariff on branded or patented pharmaceutical products. 50% tariff on kitchen cabinets, bathroom vanities, and associated products. 25% tariff on heavy trucks, effective October 1.
• 100% tariff on branded or patented pharmaceutical products.
• 50% tariff on kitchen cabinets, bathroom vanities, and associated products.
• 25% tariff on heavy trucks, effective October 1.
• The announcement underlines how trade policy shocks in the US ripple across global markets, especially for India’s export-driven pharma sector.
Background
• Section 232 of the Trade Expansion Act, 1962 Allows tariffs if imports threaten national security. Trump administration is increasingly relying on this, as tariffs under the International Emergency Economic Powers Act (IEEPA) face judicial challenges. Previous Section 232 actions targeted steel, aluminium, auto parts, and copper.
• Allows tariffs if imports threaten national security.
• Trump administration is increasingly relying on this, as tariffs under the International Emergency Economic Powers Act (IEEPA) face judicial challenges.
• Previous Section 232 actions targeted steel, aluminium, auto parts, and copper.
• Nature of New Tariffs Sector-specific, not country-specific. Focused on branded and patented medicines (not generics). If limited to patented drugs, India’s impact may be smaller as India specializes in generics. However, “branded generics” could fall under ambiguity, raising uncertainty.
• Sector-specific, not country-specific.
• Focused on branded and patented medicines (not generics).
• If limited to patented drugs, India’s impact may be smaller as India specializes in generics.
• However, “branded generics” could fall under ambiguity, raising uncertainty.
Impact on India’s Pharmaceutical Sector
• Export Dependence India’s pharma exports to the US: ~USD 8 billion annually (US FDA approval critical for market access). Around 40% of India’s pharma exports go to the US, making India vulnerable to such policy shocks.
• India’s pharma exports to the US: ~USD 8 billion annually (US FDA approval critical for market access).
• Around 40% of India’s pharma exports go to the US, making India vulnerable to such policy shocks.
• Stock Market Reaction Investors anticipate reduced margins and higher costs. Pharma index drop reflects future earnings uncertainty.
• Investors anticipate reduced margins and higher costs.
• Pharma index drop reflects future earnings uncertainty.
• Differential Impact Patented drug exporters (fewer in number) may face the brunt. Generic drug makers may escape direct impact, but supply chains linked with “branded generics” risk disruption.
• Patented drug exporters (fewer in number) may face the brunt.
• Generic drug makers may escape direct impact, but supply chains linked with “branded generics” risk disruption.
• Long-term Risk Rising protectionism in the US may erode India’s role as the “pharmacy of the world.” Companies may face stricter scrutiny under FDA compliance and pricing pressures.
• Rising protectionism in the US may erode India’s role as the “pharmacy of the world.”
• Companies may face stricter scrutiny under FDA compliance and pricing pressures.
Broader Trade Dimensions
• India–US Trade Relations Trade tensions are not new: tariffs on steel/aluminium, withdrawal of GSP benefits, and visa fee hikes have already tested ties. Pharma tariffs deepen mistrust, though both nations remain strategic partners in other domains (defence, Indo-Pacific cooperation).
• Trade tensions are not new: tariffs on steel/aluminium, withdrawal of GSP benefits, and visa fee hikes have already tested ties.
• Pharma tariffs deepen mistrust, though both nations remain strategic partners in other domains (defence, Indo-Pacific cooperation).
• Global Trade Trends Trump’s strategy: reduce trade deficits and bring manufacturing back to the US. Sectoral tariffs indicate a shift away from multilateral rules (WTO) to unilateral trade policy. Potential future targets: semiconductors, electronics, medical devices.
• Trump’s strategy: reduce trade deficits and bring manufacturing back to the US.
• Sectoral tariffs indicate a shift away from multilateral rules (WTO) to unilateral trade policy.
• Potential future targets: semiconductors, electronics, medical devices.
Policy Options for India
• Trade Negotiations Urgent need for a bilateral trade deal to protect key sectors like pharma, textiles, and IT. India must push for tariff exemptions or phased implementation.
• Urgent need for a bilateral trade deal to protect key sectors like pharma, textiles, and IT.
• India must push for tariff exemptions or phased implementation.
• Market Diversification Expand exports to EU, Africa, Latin America, and ASEAN to reduce over-dependence on the US. Example: Africa’s rising demand for affordable generics offers opportunities.
• Expand exports to EU, Africa, Latin America, and ASEAN to reduce over-dependence on the US.
• Example: Africa’s rising demand for affordable generics offers opportunities.
• Domestic Reforms Ease of doing business in pharma manufacturing. Incentives under PLI scheme for pharma to boost competitiveness. Faster drug approval systems to enhance domestic innovation.
• Ease of doing business in pharma manufacturing.
• Incentives under PLI scheme for pharma to boost competitiveness.
• Faster drug approval systems to enhance domestic innovation.
• Innovation Push Invest in R&D for new molecules and biosimilars, not just generics. Collaboration between Indian companies and global research institutions.
• Invest in R&D for new molecules and biosimilars, not just generics.
• Collaboration between Indian companies and global research institutions.
Economic and Strategic Implications
• Economic Short-term: fall in stock market capitalization, export revenue hit. Medium-term: push for innovation and new market linkages. Possible impact on employment in the pharma industry (which employs millions).
• Short-term: fall in stock market capitalization, export revenue hit.
• Medium-term: push for innovation and new market linkages.
• Possible impact on employment in the pharma industry (which employs millions).
• Strategic India’s role as a reliable global health supplier (COVID-19 vaccine diplomacy) may face credibility challenges if access narrows. Trade frictions may spill into strategic partnerships, affecting trust.
• India’s role as a reliable global health supplier (COVID-19 vaccine diplomacy) may face credibility challenges if access narrows.
• Trade frictions may spill into strategic partnerships, affecting trust.
• Public Health US consumers may face higher medicine prices if tariffs are passed on, since branded drugs are already costly. Tariffs could distort global medicine supply chains.
• US consumers may face higher medicine prices if tariffs are passed on, since branded drugs are already costly.
• Tariffs could distort global medicine supply chains.
Way Forward for India
• Short-term: Engage in diplomatic lobbying in Washington. Use WTO dispute settlement if tariffs appear discriminatory.
• Engage in diplomatic lobbying in Washington.
• Use WTO dispute settlement if tariffs appear discriminatory.
• Medium-term: Strengthen domestic R&D ecosystem. Expand South-South pharma trade partnerships.
• Strengthen domestic R&D ecosystem.
• Expand South-South pharma trade partnerships.
• Long-term: Position India as not just a generic producer, but also an innovator in biopharma and biotechnology. Build resilience through diversified global supply chains.
• Position India as not just a generic producer, but also an innovator in biopharma and biotechnology.
• Build resilience through diversified global supply chains.
Conclusion
• The US tariff shock underlines the vulnerability of India’s export-led sectors to global policy changes. The incident serves as a reminder that global economic nationalism is rising, and India must adapt with agility, foresight, and resilience.
“Examine the impact of unilateral tariff measures by the US on India–US trade relations. How should India respond to such challenges while maintaining strategic partnership?” (250 Words)